Here are relevant reports on : artificial-intelligence-ai-in-research-development-market

• Geospatial Solutions Market by Technology (Earth Observation, Scanning), Solution (Hardware, Software, Service), End-User (Utility, Business, Transportation, Defense & Intelligence, Infrastructural Development), Application, Region – Global Forecast to 2024

  The geospatial solutions market is expected to grow from USD 239.1 billion in 2019 to 502.6 billion by 2024, at a compound annual growth rate (CAGR) of 13.2% during the forecast period.The report includes the profiles of some of the top players in the geospatial solutions market to enable an in-depth understanding of the competitive landscape. Some of the key players are HERE (the Netherlands), Esri (US), Hexagon (Sweden), Atkins Plc (UK), Pitney Bowes (US), Topcon (Japan), DigitalGlobe Inc (Maxar Group) (US), General Electric (US), Harris Corporation (US), Google (US), Bentley (UK), Geospatial Corporation (US), Baidu (China), Telenav (US), TomTom International B.V. (the Netherlands), Apple (US), Oracle (US), Microsoft (US), Amazon (US), IBM (US), SAP (US), China Geo-Engineering Corporation (CGC) (China), RMSI (India), and Orbital Insights (US). The leading players are adopting various strategies to increase their share in the geospatial solutions market.

  • Published: July 2019
  • Price: $ 4950
  • TOC Available:

• Aerospace & Defense Core Materials Market by Type (Foam, Balsa, and Honeycomb), Application (Airframe Manufacturers, Aerostructures Manufacturers, Research & Development, Maintenance, Repair, and Overhaul (MRO), Original Equipment Manufacturers (OEMs)), and Region - Forecast to 2030

  The aerospace & defense core materials market is expected to grow from USD 0.47 billion in 2025 to USD 0.88 billion by 2030, at a CAGR of 13.3% during the forecast period. Prominent companies include Hexcel Corporation (US), Plascore Incorporated (US), The Gill Corporation (US), SCHÜTZ Composites (Germany), Corex Honeycomb (UK), Euro-Composites (Luxembourg), Gurit Holding AG (Switzerland), ACP Composites (US), Diab Group (Sweden), Armacell International (Luxembourg), General Plastics Manufacturing Co. (US), Evonik Industries (Germany), SABIC (Saudi Arabia), Kineco Limited (India), HONYLITE Pvt. Ltd. (India), and 3A Composites (Switzerland).

  • Published: May 2026
  • Price: $ 4950
  • TOC Available:

• Synthetic Data Generation Market by Offering (Solution/Platform and Services), Data Type (Tabular, Text, Image, and Video), Application (AI/ML Training & Development, Test Data Management), Vertical and Region - Global Forecast to 2028

  The global synthetic data generation size is projected to reach USD 2.1 billion by 2028 at a Compound Annual Growth Rate (CAGR) of 45.7% during the forecast period. Major vendors in the synthetic data generation market include Microsoft (US), Google (US), IBM (US), AWS (US), NVIDIA (US), OpenAI (US), Informatica (US), Broadcom (US), Sogeti (France), Mphasis (India), Databricks (US), MOSTLY AI (Austria), Tonic (US), MDClone (Israel) TCS (India), Hazy (UK), Synthesia (UK), Synthesized (UK), Facteus (US), Anyverse (Spain), Neurolabs (Scotland), Rendered.ai (US), Gretel (US), OneView (Israel), GenRocket (US), YData (US), CVEDIA (UK), Syntheticus (Switzerland), AnyLogic (US), Bifrost AI (US), Anonos (US).

  • Published: May 2023
  • Price: $ 4950
  • TOC Available:

• Composite AI Market by Offering (Software, Hardware, Services), Technique (Data Processing, Pattern Recognition), Application (Product Design & Development, Customer Service), Vertical and Region - Global Forecast to 2028

  The composite AI market is projected to reach USD 4.4 billion by 2028, at a CAGR of 36.5% during the forecast period. Major vendors in the global composite AI market are IBM (US), SAS Institute (US), Microsoft (US), Google (US), AWS (US), Salesforce (US), BlackSwan Technologies (Israel), Oracle (US), OpenText (Canada), SAP (Germany), HPE (US), Pega (US), NVIDIA (US), Intel (US), UiPath (US), Zest AI (US), Dynamic Yield(US), DataRobot(US), H2O.ai(US), Squirro(Switzerland), CognitiveScale(US), SparkCognition (US), Diwo(US), ACTICO (Germany), Kyndi(US), Nauto(US), Netra(US), and Exponential AI (US).

  • Published: May 2023
  • Price: $ 4950
  • TOC Available:

• Immune Repertoire Sequencing Market by Product (Instrument, Software, Assay Kit & Reagent (TCR, BCR Kit)), Technology (Sequencing, Bioinformatics), Service (Data Analysis), Application (Research, Drug Discovery & Development) - Global Forecast to 2030

  Global immune repertoire sequencing market valued at $344.2M in 2024, reached $354.6M in 2025, and is projected to grow at a robust 9.6% CAGR, hitting $560.5M by 2030. The growth of the Asia Pacific IRS market is primarily due to growing R&D investments and the increasing presence of major industry stakeholders in the region.

  • Published: April 2025
  • Price: $ 4950
  • TOC Available:

• Cell Line Development Market by Product (Equipment, Media and Reagents), Source, type & by Application ( Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research, Drug Discovery) - Analysis & Global Forecast to 2019

  The global cell line development market is expected to reach 3.96 billion by 2019 from $2.2 billion in 2014, and is expected to grow at a CAGR of 12.5% from 2014 to 2019. The market is dominated by North America, followed by Europe, Asia, and Rest of the World (RoW). North America is expected to maintain its leadership position in the market in the coming years.

  • Published: September 2014
  • Price: $ 4950
  • TOC Available:

• Custom Antibody Market by Service (Development, Purification, Fragmentation, Labeling), Type (mAbs, pAbs, rAbs), Source (Rabbit, Mice), Application (Research, Therapeutics), Indication (Oncology, Immunology, Infectious, CVD) - Global Forecast to 2029

  The global custom antibody market, valued at US$539 million in 2023, stood at US$579 million in 2024 and is projected to advance at a resilient CAGR of 9.2% from 2024 to 2029, culminating in a forecasted valuation of US$901 million by the end of the period. The market's growth is mainly driven by government funding and support for research in antibody-related fields, coupled with the expansion into translational medicine.

  • Published: June 2024
  • Price: $ 4950
  • TOC Available:

• Oligonucleotide CDMO Market by Service (Contract Manufacturing (Clinical, Commercial), Development), Type (ASO, SiRNA, (CPG Oligos, gRNA)), Application (Therapeutic, Research, Diagnostic), End User (Pharma, Biotech) - Global Forecast to 2029

  The global oligonucleotide CDMO market, valued at US$2.33 billion in 2023, stood at US$2.51 billion in 2024 and is projected to advance at a resilient CAGR of 21.8% from 2024 to 2029, culminating in a forecasted valuation of US$6.73 billion by the end of the period. The increasing focus on precision/personalized medicine is also likely to contribute to market growth. Growing opportunities offered by emerging economies are accelerating innovation in the oligonucleotide CDMO field.

  • Published: January 2025
  • Price: $ 4950
  • TOC Available:

• Latin America Cloud Computing Market by Service Model [IaaS (Compute, Storage, Networking), PaaS (Application Development & Integration, Database & Data Analytics & Reporting), SaaS (CRM, SCM, Collaboration & Productivity)], Impact of AI-Forecast to 2030

  The Latin America cloud computing market size is projected to reach 125.46 billion by 2030. The key players include Microsoft (US), Google (US), IBM (US), AWS (US), Oracle (US), Salesforce (US), Tencent Cloud (China), SAP (Germany), Alibaba Cloud (China), Huawei (China), EdgeUno (US), Zenlayer (US), Ascenty (Brazil), TIVIT (Brazil) and Claro Cloud (Brazil).

  • Published: May 2026
  • Price: $ 4950
  • TOC Available:

• Recombinant Proteins Market by Product (Growth Factors, Chemokines, Structural Proteins, Membrane Proteins), Application (Drug Discovery & Development (Biologics, Vaccines, Cell & Gene Therapy), Research, Biopharma Production) & Region - Global Forecast to 2028

  The global recombinant proteins market, valued at US$2.1 billion in 2022, stood at US$2.2 billion in 2023 and is projected to advance at a resilient CAGR of 7.2% from 2023 to 2028, culminating in a forecasted valuation of US$3.2 billion by the end of the period. Growth in the market can be attributed to factors such as rising incidence of chronic diseases, growing demand for biologics and biosimilars due to expiration of patents, rising demand for customized medicine and increasing government initiatives for R&D in life sciences research.

  • Published: January 2024
  • Price: $ 4950
  • TOC Available:

• FIRST
• PREVIOUS

Records 41 to 50 of 50